Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CD98hc-targeted antibody shuttles for central nervous system delivery with broad cross-species reactivity.

Nature biomedical engineering·2026
Same author

Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties.

mAbs·2026
Same author

A novel imaging-based multi-sample viscometry application for advancing monoclonal antibody development.

Methods and applications in fluorescence·2026
Same author

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

mAbs·2026
Same author

Proactive haemodynamic management using the hypotension prediction index during caesarean section: a randomised controlled study.

Anaesthesia·2026
Same author

Combining antibody conjugates with cytotoxic and immune-stimulating payloads maximizes anti-cancer activity.

Molecular oncology·2026

相关实验视频

Updated: Jul 1, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.6K

使用可解释机器学习来降低单克隆抗体粘度.

Emily K Makowski1,2, Hsin-Ting Chen2,3, Tiexin Wang2,3

  • 1Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.

mAbs
|March 13, 2024
PubMed
概括

本研究引入了一种机器学习模型,使用可变区域序列预测抗体粘度. 它确定了像异电点这样的关键特征,以指导抗体治疗药物的开发,并改进了类似药物的特性.

关键词:
抗体工程是一种抗体工程.在Fvv Fvv收费收费收费收费收费收费收费收费收费收费计算计算的计算方式开发能力 开发能力这是一种配方配方.疏水性是指对水的疏水性.在的中.电离点是电离点的电离点.突变是一种突变.

更多相关视频

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K
Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

416

相关实验视频

Last Updated: Jul 1, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.6K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K
Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

416

科学领域:

  • 生物技术是生物技术.
  • 蛋白质工程是指蛋白质的工程.
  • 计算生物学 计算生物学

背景情况:

  • 早期识别具有有利药物样性质的抗体候选者对于有效的治疗开发至关重要.
  • 皮下抗体配方需要较低的自我关联才能达到高度,同时最大限度地降低粘度,不透明度和聚合.

研究的目的:

  • 开发一种可解释的机器学习模型,基于可变 (Fv) 区域序列来预测抗体 (IgG1) 粘度.
  • 确定与抗体粘度相关的关键Fv序列特征.

主要方法:

  • 一个机器学习模型被训练到抗体粘度数据 (>100 mg/mL mAb度) 在pH值5.2.
  • 该模型利用抗体序列来预测粘度,重点关注Fv区域特征:同电点 (pI),疏水性补丁大小和负电荷补丁数.
  • 模型性能在训练,测试和先前报告的数据集上得到验证.

主要成果:

  • 该模型确定了低Fv同电点 (pI <6.3) 作为跨多种抗体生殖系和临床阶段IgG1s的高抗体粘度的主要预测因素.
  • 开发的模型在识别粘性抗体方面表现出很高的准确性.
  • 该模型的可解释性促进了对突变的设计,这些突变在实验中降低了抗体粘度.

结论:

  • 一个可解释的机器学习模型可以从Fv序列中预测抗体粘度,有助于早期识别类似药物的抗体候选者.
  • 低Fv pI是导致抗体粘度高的一个重要因素.
  • 这种方法可以通过减少实验查和改善候选人选择来简化抗体药物开发.